MSH3 and pancreatic neoplasm: It remains to be determined whether MSH3 copy number alterations, found in 32% of the TCGA colorectal and 27% of the pancreatic cancer cohort (Figure 3a,c), are associated with the EMAST/non-MSI-H phenotype.